These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23102249)

  • 1. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer.
    Shiwu WU; Lan Y; Wenqing S; Lei Z; Yisheng T
    Arch Iran Med; 2012 Nov; 15(11):707-12. PubMed ID: 23102249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry].
    Wu S; Cheng Z; Yu L; Song W; Tao Y
    Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):918-25. PubMed ID: 22152691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.
    Wang Y; Yang R; Wang X; Ci H; Zhou L; Zhu B; Wu S; Wang D
    Medicine (Baltimore); 2018 Dec; 97(52):e13817. PubMed ID: 30593175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of Gal-3 and CD82/KAI1 proteins in non-small cell lung cancer and their clinical significance].
    Wu SW; Yu L; Zhou L; Cheng ZN; Tao YS
    Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):124-8. PubMed ID: 23714667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis.
    Higashiyama M; Kodama K; Yokouchi H; Takami K; Adachi M; Taki T; Ishiguro S; Nakamori S; Yoshie O; Miyake M
    Cancer; 1998 Aug; 83(3):466-74. PubMed ID: 9690539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.
    Yu L; Zhou L; Wu S; Gong X; Feng Z; Ma L; Zhu B; Yao N; Wang D; Dong H
    World J Surg Oncol; 2014 Apr; 12():118. PubMed ID: 24758564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expressions of KAI1 and E-cadherin in nonsmall cell lung cancer and their correlation with vasculogenic mimicry.
    Ci H; Xu Z; Xu J; Wang Y; Wu S
    Medicine (Baltimore); 2018 Oct; 97(40):e12293. PubMed ID: 30290593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
    Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
    Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
    Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
    Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.
    Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D
    Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer.
    Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X
    World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between the levels of KAI1/CD82 and CD44 and the clinicopathological features of non-small cell lung cancer].
    Chen QY; Lin XM; Zhou JY; An Z; Yang L; Jiang ZY
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):101-4. PubMed ID: 14990184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma.
    Protzel C; Kakies C; Kleist B; Poetsch M; Giebel J
    Virchows Arch; 2008 Apr; 452(4):369-75. PubMed ID: 18305955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
    Zeng TD; Zheng B; Zheng W; Chen C
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma.
    Prabhu VV; Devaraj SN
    J Environ Pathol Toxicol Oncol; 2017; 36(3):269-275. PubMed ID: 29283339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression.
    Adachi M; Taki T; Konishi T; Huang CI; Higashiyama M; Miyake M
    J Clin Oncol; 1998 Apr; 16(4):1397-406. PubMed ID: 9552043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.
    Guo C; Liu QG; Zhang L; Song T; Yang X
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
    Choi UJ; Jee BK; Lim Y; Lee KH
    Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model.
    Takeda T; Hattori N; Tokuhara T; Nishimura Y; Yokoyama M; Miyake M
    Cancer Res; 2007 Feb; 67(4):1744-9. PubMed ID: 17308116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
    Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
    Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.